US0383361039 - Common Stock
APTARGROUP INC
NYSE:ATR (9/6/2024, 8:04:00 PM)
After market: 152.38 0 (0%)152.38
+1.66 (+1.1%)
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. The company is headquartered in Crystal Lake, Illinois and currently employs 13,800 full-time employees. The firm serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The firm operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP INC
265 Exchange Drive, Suite 301
Crystal Lake ILLINOIS 60014
P: 18154770424
CEO: Stephan B. Tanda
Employees: 13800
Website: https://www.aptar.com/
ATR stock results show that AptarGroup beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AptarGroup (NYSE:ATR) just reported results for the second quarter of 2024.Apta...
Here you can normally see the latest stock twits on ATR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: